Tumour Immunology


Tumour Immunology

A/Prof Lisa Ebert  (Chairperson)
Centre for Cancer Biology, SA
[email protected]

A/Prof Mainthan Palendira
University of Sydney, NSW
[email protected]

Prof Thomas Gebhardt
The Peter Doherty Institute for Infection and Immunity, VIC
[email protected]

Dr Kirsten Ward-Hartstonge 
University of Otago
[email protected]

Dr Ben Wylie
Telethon Kids Cancer Centre, WA
j[email protected]

Tumour Immunology - An overview

Tumour Immunology encompasses the study of immune responses toward cancer cells, and the development of approaches to treat cancer using components of the immune system. It is an exciting field to be a part of right now! Although the ability of the immune system to recognise and eliminate cancer cells has been recognised for many decades, it is only recently that we have been able to use this knowledge to start effectively treating cancer.

Researchers in this field have diverse interests, including the study of innate and adaptive responses to cancer, elucidating mechanisms of immune resistance, development of novel cancer immunotherapies, and identification of personalised medicine strategies.


The main purpose of the Tumour Immunology SIG is to promote collaboration and spark new ideas within the fields of basic and applied tumour immunology, including cancer immunotherapy. The SIG is managed by a dedicated group of ASI members (see Committee Members, above) who have a particular interest in this field. If you would like to get involved or discuss joining the committee, please contact the Chairperson, A/Prof Lisa Ebert.

The SIG hosts a full-day Tumour Immunology workshop each year in conjunction with the ASI Annual Scientific Meeting. This workshop generally attracts ~70-100 delegates each year and consists of a program of plenary talks plus short presentations selected from abstracts. The workshop is of interest to both fundamental and cancer immunologists, as well as clinician researchers. On occasion, the Tumour Immunology Workshop may be co-hosted with the Stromal Immunology Workshop, due to the overlapping interests of these two SIGs.

We may also organise additional events throughout the year focussed on Tumour Immunology. Stay tuned to this page for details, or head into the ‘Your Details’ section of your ASI member profile and select ‘Tumour Immunology’ as one of your interests to become a member of the SIG and be kept up to date with our activities. 

Did you know that the Tumour Immunology SIG was established in 1998, making it one of the oldest SIGs within ASI? For further history and information about the SIG, as well as fascinating interviews with leaders in the field, check out our open access Commentary article published by Immunology and Cell Biology as part of its 100-year anniversary celebrations: doi: 10.1111/imcb.12690.

© ASI 2021

ABN 76 330 189 856 | ARBN 084 971 559 | CAV A0016266B